title: Randomized, double-blind trial of prostaglandin E2 intravaginal gel versus low-dose oxytocin for cervical ripening before induction of labor.
abstract: OBJECTIVE
  Our purpose was to compare two methods of preinduction cervical ripening in a randomized, double-blind clinical trial.
  
  
  METHODS
  Two intravaginal, 4 mg prostaglandin E2 gel applications administered 4 hours apart were compared with 10 hours of low-dose oxytocin (2 mU/min) in 200 patients undergoing preinduction cervical ripening.
  
  
  RESULTS
  There were no differences in parity, initial Bishop scores, estimated gestational ages, indications for induction, or birth weights. Prostaglandin E2 gel was significantly better (p < 0.0001) at achieving a change in the Bishop score of 3 or more. The number of successful inductions was significantly greater (p < 0.0003) and the mean time to active labor was significantly shorter (p < 0.0002) in the prostaglandin E2 group than in the oxytocin group. More multiple-day inductions (p < 0.01) occurred in the oxytocin group, and fewer discharged patients who did not deliver infants (p < 0.03) were seen in the prostaglandin E2 gel group. There were no differences between patient groups in the cesarean section rate, meconium staining, hyperstimulation, and Apgar scores.
  
  
  CONCLUSIONS
  Two 4 mg doses of prostaglandin E2 intravaginal gel applied 4 hours apart are superior to low-dose oxytocin in producing cervical ripening and preparing for successful induction.
authors.affiliation: University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, 53201, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Pollnow
authors.forename: F F
authors.initials: FF
authors.lastname: Broekhuizen
mesh_terms: D000282:Administration, Intravaginal; D002584:Cervix Uteri / Q000187:drug effects / Q000502:physiology*; D015232:Dinoprostone / Q000008:administration & dosage* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D005782:Gels; D006801:Humans; D007751:Labor, Induced; D010120:Oxytocics / Q000008:administration & dosage* / Q000627:therapeutic use; D010121:Oxytocin / Q000008:administration & dosage* / Q000627:therapeutic use; D011247:Pregnancy
chemical_list: D005782:Gels; D010120:Oxytocics; D010121:Oxytocin; D015232:Dinoprostone